FTC sues big pharmacy profit managers around insulin prices The company introduced action towards Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the record cost of daily life-conserving insulin medication. Sanders quickly condemned the transfer in an announcement Wednesday, noting he was dissatisfied https://buschpeachcalories87384.topbloghub.com/36946865/an-unbiased-view-of-healthcare-news